文献速递中枢神经肿瘤放疗放疗物理与技术

脑转移瘤单等中心放射外科3次与5次分割方案比较

Comparison of 3 vs 5 Fraction Single Isocenter Radiosurgery for Brain Metastases.
PubMed 文献 · Adv Radiat Oncol · 2025-10-23

该回顾性研究分析了251例患者1215个脑转移瘤,比较9 Gy×3次与6 Gy×5次单等中心容积调强弧形治疗的分割立体定向放射外科方案。

要点

  • 9 Gy×3次方案1年局部控制率97%,优于6 Gy×5次的91%。
  • 肿瘤<2cm时3次方案控制率99%,显著优于5次方案的95%。
  • 两组1年≥3级中枢神经系统毒性无显著差异(99% vs 96%)。

核心结论

  • 9 Gy×3次分割方案较6 Gy×5次方案局部控制更优且毒性相当,尤其适用于<2cm的脑转移瘤。

研究设计与样本

  • 回顾性研究纳入251例患者共1215个脑转移瘤,均接受单等中心容积调强弧形治疗的分割立体定向放射外科,排除复发肿瘤和术后瘤腔。

主要发现

  • 总体1年局部控制率93%,2年88%。

关键数值与推荐

  • 局部肿瘤失败定义为最大肿瘤直径增加25%(最小3mm)或补救手术时发现超过少量肿瘤细胞。
  • 毒性采用CTCAE V5.0中枢神经系统≥3级事件。

临床怎么用

  • 对多发性脑转移瘤采用单等中心放射外科时,9 Gy×3次方案可提高效率并改善局部控制,尤其对<2cm肿瘤可优先考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Single isocenter stereotactic radiosurgery (SRS) efficiently delivers radiation to patients with multiple brain metastases. Although several fractionated SRS (fSRS) regimens show acceptable local control and toxicity, few studies directly compare them. This retrospective study evaluates 2 common regimens-6 Gy × 5 fractions and 9 Gy × 3 fractions-for their effects on local control and toxicity. METHODS AND MATERIALS: A retrospective review was conducted of 1215 brain tumors from 251 patients receiving either 9 Gy × 3 fx or 6 Gy × 5 fx fSRS. All tumors were treated with single isocenter volumetric modulated arc therapy. Recurrent tumors and postoperative cavities were excluded from the analysis. Local tumor failure was defined as 25% increase in maximum tumor diameter (minimum 3 mm) or more than scant tumor cells at time of salvage surgery. Toxicity included CTCAE V5.0 central nervous system (CNS) grade 3 or greater events. Local tumor control and freedom from toxicity were calculated using Kaplan-Meier method and Cox regression models. RESULTS: Overall local control was 93% at 1 year and 88% at 2 years. The 3-fraction regimen had superior 1-year local control compared with the 5-fraction regimen (97% vs. 91%, P = .001). Tumors <2 cm had significantly better control with 3 fractions (99% vs. 95%, P = .004), whereas tumors 2-4 cm showed no significant difference. One-year freedom from grade 3+ toxicity was similar between regimens (99% for 3-fx vs. 96% for 5-fx, P = .097). CONCLUSIONS: In this study, 9 Gy × 3 fx for brain metastases had improved tumor control and comparable toxicity to 6 Gy × 5, particularly among tumors <2 cm. 9 Gy × 3 fx may be the preferred regimen when treating multiple tumors with one prescription using single isocenter radiosurgery as it improves efficiency and local control while having similar toxicity.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Moradi LA, Popple RA, Travis RL, et al. Comparison of 3 vs 5 Fraction Single Isocenter Radiosurgery for Brain Metastases. Adv Radiat Oncol. 2025. PMID: 41767405. doi:10.1016/j.adro.2025.101927

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。